Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 11—November 2010

Dispatch

Multidrug-Resistant Salmonella enterica Serovar Infantis, Israel

Ohad Gal-MorComments to Author , Lea Valinsky, Miriam Weinberger, Sara Guy, Joseph Jaffe, Yosef Ilan Schorr, Abraham Raisfeld, Vered Agmon, and Israel Nissan
Author affiliations: Sheba Medical Center, Tel-Hashomer, Israel (O. Gal-Mor); Ministry of Health Laboratories, Jerusalem, Israel (L. Valinsky, S. Guy, J. Jaffe, Y.I. Schorr, A. Raisfeld, V. Agmon, I. Nissan); Assaf Harofeh Medical Center, Zerifin, Israel (M. Weinberger)

Main Article

Table

Antimicrobial drug resistance patterns of Salmonella enterica serovar Infantis isolates, sorted by isolation year, Israel*

Antimicrobial drug resistance profile PFGE pattern
1970–2005
2007
2008
2009
Total
I1 D I1 D I1 D I1 D
Ampicillin, cefuroxime, ceftriaxone, cephalothin, nitrofurantoin, trimethoprim/sulfamethoxazole 1 1
Ampicillin, cefepime, ceftriaxone, cephalothin, cefuroxime, tobramycin 1 1
Nitrofurantoin 5 5
Nitrofurantoin, tetracycline 1 1
Levofloxacin, nalidixic acid 1 1
Nalidixic acid, nitrofurantoin, tetracycline 1 1 37 3 8 3 53
Nalidixic acid, nitrofurantoin, tetracycline, cephalothin 1 1
Nalidixic acid, nitrofurantoin, tetracycline, trimethoprim/sulfamethoxazole 2 1 1 10 1 15
Nalidixic acid, tetracycline, trimethoprim/sulfamethoxazole 1 1
Nalidixic acid, tetracycline 1 1
Nalidixic acid, trimethoprim/sulfamethoxazole

1










1
Sensitive to all tested antimicrobial drugs

6










6
Total 16 2 3 47 7 9 3 87

*PFGE, pulsed-field gel electrophoresis; I1, emerging PFGE pattern; D, different from the emerging pattern.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO